In vitro adherence properties of Lactobacillus rhamnosus DR20 and Bifidobacterium lactis DR10 strains and their antagonistic activity against an enterotoxigenic Escherichia coli.
about
Potential uses of probiotics in clinical practicePhenotypic and Genotypic Characteristics of Small Colony Variants and Their Role in Chronic InfectionLactobacillus adhesion to mucusIn vitro and in vivo evaluation of the prebiotic effect of raw and roasted almonds (Prunus amygdalus)The Lactobacillus plantarum strain ACA-DC287 isolated from a Greek cheese demonstrates antagonistic activity in vitro and in vivo against Salmonella enterica serovar TyphimuriumDirect selection and phage display of a Gram-positive secretomeThe Probiotic Compound VSL#3 Modulates Mucosal, Peripheral, and Systemic Immunity Following Murine Broad-Spectrum Antibiotic Treatment.Lactobacillus johnsonii ameliorates intestinal, extra-intestinal and systemic pro-inflammatory immune responses following murine Campylobacter jejuni infectionComparison of Salmonella enterica serovar Typhimurium colitis in germfree mice and mice pretreated with streptomycin.Adhesion and immunomodulatory effects of Bifidobacterium lactis HN019 on intestinal epithelial cells INT-407.Probiotic potential of Lactobacillus strains with antimicrobial activity against some human pathogenic strainsIntestinal microbiota in pathophysiology and management of irritable bowel syndrome.A Lactobacillus acidophilus strain of human gastrointestinal microbiota origin elicits killing of enterovirulent Salmonella enterica Serovar Typhimurium by triggering lethal bacterial membrane damage.pH-, Lactic acid-, and non-lactic acid-dependent activities of probiotic Lactobacilli against Salmonella enterica Serovar Typhimurium.The effect of cell surface components on adhesion ability of Lactobacillus rhamnosus.Bifidobacteria-host interactions--an update on colonisation factors.The front line of enteric host defense against unwelcome intrusion of harmful microorganisms: mucins, antimicrobial peptides, and microbiotaEffect of L. plantarum cell-free extract and co-trimoxazole against Salmonella Typhimurium: a possible adjunct therapy.Need for a comprehensive medical approach to the neuro-immuno-gastroenterology of irritable bowel syndromeInactivation of adhesion and invasion of food-borne Listeria monocytogenes by bacteriocin-producing Bifidobacterium strains of human origin.Characterization of indigenous lactobacillus strains for probiotic propertiesProbiotics to counteract biofilm-associated infections: promising and conflicting dataLive probiotics protect intestinal epithelial cells from the effects of infection with enteroinvasive Escherichia coli (EIEC)Probiotic cheese containing Lactobacillus rhamnosus HN001 and Lactobacillus acidophilus NCFM® modifies subpopulations of fecal lactobacilli and Clostridium difficile in the elderlyAntagonistic activities of lactobacilli and bifidobacteria against microbial pathogens.EPS-SJ Exopolisaccharide Produced by the Strain Lactobacillus paracasei subsp. paracasei BGSJ2-8 Is Involved in Adhesion to Epithelial Intestinal Cells and Decrease on E. coli Association to Caco-2 Cells.Effects of Panax notoginseng on the Metastasis of Human Colorectal Cancer Cells.Effect of dietary supplementation with a probiotic (Enterococcus faecium) on production performance, excreta microflora, ammonia emission, and nutrient utilization in ISA brown laying hens.Study of the Ability of Bifidobacteria of Human Origin to Prevent and Treat Rotavirus Infection Using Colonic Cell and Mouse Models.Bifidobacterium adolescentis Exerts Strain-Specific Effects on Constipation Induced by Loperamide in BALB/c Mice.In vitro assessment of Pediococcus acidilactici Kp10 for its potential use in the food industryCompetition of Lactobacillus paracasei with Salmonella enterica for adhesion to Caco-2 cells.Construction of a recombinant allergen-producing probiotic bacterial strain: Introduction of a new line for a live oral vaccine against Chenopodium album pollen allergyThe antimicrobial effect of lactobacillus casei culture supernatant against multiple drug resistant clinical isolates of Shigella sonnei and Shigella flexneri in vitro.High Iron-Sequestrating Bifidobacteria Inhibit Enteropathogen Growth and Adhesion to Intestinal Epithelial Cells In vitroAnimal Enterotoxigenic Escherichia coli.Integrated Role of Bifidobacterium animalis subsp. lactis Supplementation in Gut Microbiota, Immunity, and Metabolism of Infant Rhesus MonkeysClinical detection of human probiotics and human pathogenic bacteria by using a novel high-throughput platform based on next generation sequencing.Amelioration of intestinal and systemic sequelae of murine Campylobacter jejuni infection by probiotic VSL#3 treatment.Potential role of probiotic bacteria in the treatment and prevention of localised candidosis.
P2860
Q24681377-DB62197C-00C3-435D-893A-F47F9A7CBE98Q26786112-0877C3CC-C1D3-4149-9D03-B4863EEA613FQ26827553-D27D9E7B-6FCA-49D7-8817-7F0950E2E6B3Q28821853-EDC65D7C-8815-4AB1-97A9-FDC17B3839A3Q29397388-02B29EB4-DE3B-4DA2-918C-08FE470F8CFFQ33310217-62DF0509-04AC-4C9B-9098-BA5D73E1B9B7Q33639134-E32BC422-1E2A-40CA-8730-D2F8987902A9Q33705072-8FD24445-A5DC-45C5-A4D6-EEB2BF37DC1AQ33788040-B14A8484-090E-4D5F-AF33-953EB4FE4D89Q33844207-1F4AE222-25CE-4D6E-9F8C-65F3144C2D92Q33930245-1CCA27C5-C44D-4EA0-8591-20E1A463B4F6Q33958729-2A611894-6061-400A-B54B-7010D2F769B8Q34097875-25BF8468-EBE4-4564-9D14-779289209BC5Q34098013-FA190C61-9457-4680-9051-AA6CE128E77CQ34151634-A80C18EC-2E26-43DF-878B-9B7007B196FCQ34256838-57E9F719-46D4-4D34-9BFE-B5D8FEE92132Q34647328-052BA3B8-175B-4772-A106-2EBC6440D96FQ34668105-76F874C4-CAAC-4772-882D-27A8E3EE2DD2Q35061903-44227B6A-873C-4FEA-B0C2-D418E130C471Q35129994-A873C07A-CAC4-4B91-BEB7-78DBCED1F443Q35157627-7AB232EB-A9D5-4A10-AD2A-D2BD0C5131CDQ35278680-20BBE2B9-38EA-42E7-818B-B7EEC31A5B71Q35595770-BEF36B94-D486-4EE8-B10B-C288ED5F553BQ35678186-068D8283-F35A-4531-BE96-A5D2E154E114Q35890738-6A647099-EE0A-4006-A7EF-F6F622385B59Q35970059-B1DD25E6-C97D-43D6-86DF-8A3C3B99720DQ36028764-B29FDCDF-562A-44B7-9959-8AD4AEF2163AQ36079233-4769F934-C01B-43E4-9179-41508E2239F2Q36160564-D177521E-7C4B-431D-8194-67FA98FE1E67Q36288189-92E5EAEA-1533-474D-B00F-56F49500B8E0Q36378768-24526541-FE40-40B9-91FE-93CCF461F6A0Q36517851-A584CB9C-1C04-445F-84D8-F02B3B6A6303Q36589520-B3770886-0171-4176-9639-52AFEB508E68Q36839276-0752BA24-0AB4-46DA-BC46-4302B6FB6BD9Q37273581-03F040B7-EC63-4290-A235-5F83BEA9A7F8Q37441497-F33A6FF1-D957-43D4-B3F2-74F828A315B4Q37453144-0D99B758-9E4D-4782-930D-5169C1DC3560Q37514648-E104C5FD-3F8D-4A5E-B44B-3E78A6468323Q37748061-52C2A5E3-7441-4D56-9552-275F691AC9ABQ37889385-F6E56CA8-A1C7-4D5A-8004-5A9AB7955F80
P2860
In vitro adherence properties of Lactobacillus rhamnosus DR20 and Bifidobacterium lactis DR10 strains and their antagonistic activity against an enterotoxigenic Escherichia coli.
description
2001 nî lūn-bûn
@nan
2001 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
In vitro adherence properties ...... erotoxigenic Escherichia coli.
@ast
In vitro adherence properties ...... erotoxigenic Escherichia coli.
@en
type
label
In vitro adherence properties ...... erotoxigenic Escherichia coli.
@ast
In vitro adherence properties ...... erotoxigenic Escherichia coli.
@en
prefLabel
In vitro adherence properties ...... erotoxigenic Escherichia coli.
@ast
In vitro adherence properties ...... erotoxigenic Escherichia coli.
@en
P2093
P1476
In vitro adherence properties ...... erotoxigenic Escherichia coli.
@en
P2093
P304
P356
10.1016/S0168-1605(01)00440-8
P577
2001-08-01T00:00:00Z